Shenghui Chen

1.0k total citations
36 papers, 744 citations indexed

About

Shenghui Chen is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Shenghui Chen has authored 36 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Shenghui Chen's work include Liver Disease Diagnosis and Treatment (11 papers), Alcohol Consumption and Health Effects (6 papers) and interferon and immune responses (4 papers). Shenghui Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Alcohol Consumption and Health Effects (6 papers) and interferon and immune responses (4 papers). Shenghui Chen collaborates with scholars based in China, United States and Macao. Shenghui Chen's co-authors include Chengfu Xu, Jian‐Bo Wan, Jiaolin Bao, Huanxing Su, Chengwei He, Kai Wang, Xuejing Jia, Meiwan Chen, Jinghua Wang and Yanjun Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Shenghui Chen

34 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghui Chen China 14 297 162 101 76 71 36 744
Chia-Yao Shen Taiwan 19 387 1.3× 123 0.8× 74 0.7× 104 1.4× 124 1.7× 39 836
Tingting Long China 18 350 1.2× 129 0.8× 73 0.7× 114 1.5× 49 0.7× 56 988
Bo Huang China 19 433 1.5× 115 0.7× 77 0.8× 87 1.1× 109 1.5× 54 911
Weiwei Cai China 18 371 1.2× 109 0.7× 65 0.6× 94 1.2× 63 0.9× 47 896
Hyonok Yoon South Korea 14 360 1.2× 128 0.8× 54 0.5× 66 0.9× 62 0.9× 28 889
Xuexue Zhu China 14 315 1.1× 107 0.7× 48 0.5× 80 1.1× 62 0.9× 39 667
Yun‐Ho Kim South Korea 19 310 1.0× 83 0.5× 99 1.0× 47 0.6× 75 1.1× 46 910
Xin Jia China 17 492 1.7× 269 1.7× 63 0.6× 91 1.2× 123 1.7× 40 952
Yanhao He China 19 387 1.3× 131 0.8× 47 0.5× 66 0.9× 109 1.5× 23 811

Countries citing papers authored by Shenghui Chen

Since Specialization
Citations

This map shows the geographic impact of Shenghui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghui Chen more than expected).

Fields of papers citing papers by Shenghui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghui Chen. The network helps show where Shenghui Chen may publish in the future.

Co-authorship network of co-authors of Shenghui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghui Chen. A scholar is included among the top collaborators of Shenghui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghui Chen. Shenghui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yanjun, Shenghui Chen, Zhening Liu, et al.. (2025). Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation. Experimental & Molecular Medicine. 57(5). 990–1004.
2.
Guo, Yanjun, Zhening Liu, Shenghui Chen, et al.. (2025). Amyloid precursor protein promotes MASH progression by upregulating death receptor 6–mediated hepatocyte apoptosis. Journal of Biological Chemistry. 301(3). 108285–108285.
4.
Zhu, Haijing, et al.. (2024). Molecular Characteristics and Expression of TKTL1 in Germ Cells: Implications for Nontumour Cell Research. Reproduction in Domestic Animals. 59(9). e14723–e14723. 2 indexed citations
5.
Chen, Shenghui, Ruihua Wang, Mingshi Li, et al.. (2023). SUMO and PIAS repress NF-κB activation in a basal chordate. Fish & Shellfish Immunology. 137. 108754–108754. 4 indexed citations
6.
Chen, Shenghui, Xinyu Wang, Zhening Liu, et al.. (2023). Olfactomedin 4 deletion exacerbates nonalcoholic fatty liver disease through P62-dependent mitophagy in mice. Metabolism. 148. 155679–155679. 8 indexed citations
7.
Wang, Jinghua, et al.. (2022). Prevalence and risk factors of hyperuricaemia in non-obese Chinese: a single-centre cross-sectional study. BMJ Open. 12(6). e048574–e048574. 8 indexed citations
8.
Zeng, Hang, Mengli Yu, Xinyu Wang, et al.. (2022). The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease. Hepatology International. 16(5). 1064–1074. 10 indexed citations
9.
Fang, Zejun, Min Lin, Shenghui Chen, et al.. (2022). E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells. Cellular & Molecular Biology Letters. 27(1). 90–90. 15 indexed citations
10.
Liu, Zhening, Jinghua Wang, Shenghui Chen, Chengfu Xu, & Yu Zhang. (2021). Associations of acrylamide with non-alcoholic fatty liver disease in American adults: a nationwide cross-sectional study. Environmental Health. 20(1). 98–98. 10 indexed citations
11.
Zhou, Yuliang, et al.. (2021). The efficacy and safety of acupuncture in the treatment of erectile dysfunction. Medicine. 100(21). e25892–e25892. 4 indexed citations
12.
Wang, Jianbo, et al.. (2021). Esophageal Variceal Ligation Monotherapy versus Combined Ligation and Sclerotherapy for the Treatment of Esophageal Varices. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 8856048–8856048. 5 indexed citations
13.
Li, Jin, Yuhui Li, Shenghui Chen, et al.. (2021). Two Amphioxus ApeC-Containing Proteins Bind to Microbes and Inhibit the TRAF6 Pathway. Frontiers in Immunology. 12. 715245–715245. 7 indexed citations
14.
Chen, Shenghui, Dan Chen, Hua Yang, et al.. (2020). Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis. BMC Gastroenterology. 20(1). 39–39. 35 indexed citations
15.
Guo, Yanjun, et al.. (2020). Functions of amyloid precursor protein in metabolic diseases. Metabolism. 115. 154454–154454. 64 indexed citations
16.
Zhang, Xuequn, Yiming Lin, Sisi Lin, et al.. (2020). Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. Hepatology International. 14(5). 828–841. 20 indexed citations
17.
Wang, Xinyu, et al.. (2018). Olfactomedin-4 in digestive diseases: A mini-review. World Journal of Gastroenterology. 24(17). 1881–1887. 39 indexed citations
18.
Zhang, Chao, Chuwen Li, Shenghui Chen, et al.. (2017). Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways. Scientific Reports. 7(1). 41082–41082. 73 indexed citations
19.
Zhang, Chao, Chuwen Li, Shenghui Chen, et al.. (2016). Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways. Redox Biology. 11. 1–11. 143 indexed citations
20.
Zhang, Chao, Xuejing Jia, Jiaolin Bao, et al.. (2015). Polyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways. BMC Complementary and Alternative Medicine. 16(1). 58–58. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026